INTERCEPT PHARMACEUTICALS, INC. Insider Trading for July 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. for July 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 24 2015 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Sell | S | 285.00 | 582 | 165,870 | 8,221 | 8.8 K to 8.2 K (-6.61 %) |
| Jul 22 2015 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Option Exercise | M | 9.82 | 973 | 9,557 | 109 | |
| Jul 22 2015 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Sell | S | 279.01 | 973 | 271,477 | 962 | 1.9 K to 962 (-50.28 %) |
| Jul 22 2015 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Buy | M | 9.82 | 973 | 9,557 | 1,935 | 962 to 1.9 K (+101.14 %) |
| Jul 21 2015 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Grant | A | 0.00 | 285 | 0 | 1,120,609 | 1.1 M to 1.1 M (+0.03 %) |
| Jul 17 2015 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 255.12 | 503 | 128,327 | 4,420 | 4.9 K to 4.4 K (-10.22 %) |
| Jul 14 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 8.67 | 12,500 | 108,334 | 116,628 | |
| Jul 14 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 250.00 | 12,500 | 3,125,000 | 507,014 | 519.5 K to 507 K (-2.41 %) |
| Jul 14 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 8.67 | 12,500 | 108,334 | 519,514 | 507 K to 519.5 K (+2.47 %) |
| Jul 08 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Option Exercise | M | 21.50 | 4,000 | 86,000 | 2,923 | |
| Jul 08 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Option Exercise | M | 8.67 | 67 | 581 | 0 | |
| Jul 08 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Sell | S | 243.69 | 130 | 31,680 | 10,709 | 10.8 K to 10.7 K (-1.20 %) |
| Jul 08 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Sell | S | 241.81 | 770 | 186,194 | 10,839 | 11.6 K to 10.8 K (-6.63 %) |
| Jul 08 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Sell | S | 241.57 | 1,000 | 241,571 | 11,609 | 12.6 K to 11.6 K (-7.93 %) |
| Jul 08 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Sell | S | 240.63 | 1,200 | 288,752 | 12,609 | 13.8 K to 12.6 K (-8.69 %) |
| Jul 08 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Sell | S | 238.64 | 367 | 87,580 | 13,809 | 14.2 K to 13.8 K (-2.59 %) |
| Jul 08 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Sell | S | 2,538.02 | 600 | 1,522,815 | 14,176 | 14.8 K to 14.2 K (-4.06 %) |
| Jul 08 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Buy | M | 21.50 | 4,000 | 86,000 | 14,776 | 10.8 K to 14.8 K (+37.12 %) |
| Jul 08 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Buy | M | 8.67 | 67 | 581 | 10,776 | 10.7 K to 10.8 K (+0.63 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 0.00 | 1,623 | 0 | 3,245 | |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 239.00 | 41 | 9,799 | 19,005 | 19 K to 19 K (-0.22 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 238.16 | 9 | 2,143 | 19,046 | 19.1 K to 19 K (-0.05 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 236.13 | 801 | 189,140 | 19,055 | 19.9 K to 19.1 K (-4.03 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 0.00 | 1,623 | 0 | 19,856 | 18.2 K to 19.9 K (+8.90 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Option Exercise | M | 0.00 | 649 | 0 | 1,298 | |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Buy | M | 0.00 | 649 | 0 | 10,709 | 10.1 K to 10.7 K (+6.45 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 0.00 | 4,868 | 0 | 9,735 | |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 239.00 | 2 | 478 | 507,014 | 507 K to 507 K (0.00 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 238.16 | 7 | 1,667 | 507,016 | 507 K to 507 K (0.00 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 236.13 | 149 | 35,183 | 507,023 | 507.2 K to 507 K (-0.03 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 0.00 | 4,868 | 0 | 507,172 | 502.3 K to 507.2 K (+0.97 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,298 | 0 | 2,596 | |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 239.00 | 1 | 239 | 18,768 | 18.8 K to 18.8 K (-0.01 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 238.16 | 2 | 476 | 18,769 | 18.8 K to 18.8 K (-0.01 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 236.13 | 50 | 11,807 | 18,771 | 18.8 K to 18.8 K (-0.27 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 0.00 | 1,298 | 0 | 18,821 | 17.5 K to 18.8 K (+7.41 %) |
| Jul 06 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 8.67 | 1,000 | 8,667 | 7,940 | |
| Jul 06 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 242.10 | 1,000 | 242,100 | 17,523 | 18.5 K to 17.5 K (-5.40 %) |
| Jul 06 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 8.67 | 1,000 | 8,667 | 18,523 | 17.5 K to 18.5 K (+5.71 %) |
| Jul 06 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 3,500 | 30,333 | 22,794 | |
| Jul 06 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 241.81 | 100 | 24,181 | 18,233 | 18.3 K to 18.2 K (-0.55 %) |
| Jul 06 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 240.59 | 381 | 91,664 | 18,333 | 18.7 K to 18.3 K (-2.04 %) |
| Jul 06 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 239.32 | 398 | 95,251 | 18,714 | 19.1 K to 18.7 K (-2.08 %) |
| Jul 06 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 238.51 | 1,902 | 453,641 | 19,112 | 21 K to 19.1 K (-9.05 %) |
| Jul 06 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 237.64 | 1,000 | 237,640 | 21,014 | 22 K to 21 K (-4.54 %) |
| Jul 06 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 3,500 | 30,333 | 22,014 | 18.5 K to 22 K (+18.90 %) |